Mindera Health™ announces first patient enrolled in the MATCH Study: a clinical utility evaluation of the impact of Mind.Px™ on response rates of psoriasis patients who are prescribed biologics
21. Oktober 2021 12:00 ET
|
Mindera Health
San Diego, CA, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Mindera Health, developers of the ground-breaking Dermal Intelligence™ platform that is the first realization of personalized medicine in psoriasis,...
Mindera Corporation Shifts Name to Mindera Health to Sharpen Focus on Its Personalized Medicine Platform
05. Oktober 2021 11:00 ET
|
Mindera Health
San Diego, CA, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Mindera Corporation, developers of the groundbreaking Mind.Px™ - the first realization of truly personalized medicine in psoriasis - has changed its...